These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2678432)

  • 1. [New pathophysiologic aspects of nephrolithiasis].
    Hess B
    Schweiz Med Wochenschr; 1989 Jul; 119(26):929-34. PubMed ID: 2678432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of nephrocalcin in inhibition of calcium oxalate crystallization and nephrolithiasis.
    Coe FL; Nakagawa Y; Asplin J; Parks JH
    Miner Electrolyte Metab; 1994; 20(6):378-84. PubMed ID: 7783700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of Tamm-Horsfall glycoprotein and Nephrocalcin in calcium oxalate monohydrate crystallization processes.
    Hess B
    Scanning Microsc; 1991 Sep; 5(3):689-95; discussion 696. PubMed ID: 1808706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of Tamm-Horsfall mucoprotein in calcium oxalate lithogenesis].
    Gambaro G; Baggio B; Favaro S; Cicerello E; Marchini F; Borsatti A
    Nephrologie; 1984; 5(4):171-2. PubMed ID: 6441892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystallization properties in urine from calcium oxalate stone formers.
    Tiselius HG; Bek-Jensen H; Fornander AM; Nilsson MA
    J Urol; 1995 Sep; 154(3):940-6. PubMed ID: 7637098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Tamm-Horsfall protein and uromodulin in calcium oxalate crystallization.
    Carvalho M; Mulinari RA; Nakagawa Y
    Braz J Med Biol Res; 2002 Oct; 35(10):1165-72. PubMed ID: 12424489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamm-Horsfall glycoprotein and calcium nephrolithiasis.
    Hess B
    Miner Electrolyte Metab; 1994; 20(6):393-8. PubMed ID: 7783702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic urinary correlates of calcium oxalate dihydrate in renal stones.
    Asplin JR; Lingeman J; Kahnoski R; Mardis H; Parks JH; Coe FL
    J Urol; 1998 Mar; 159(3):664-8. PubMed ID: 9474121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins.
    Hess B; Nakagawa Y; Coe FL
    Am J Physiol; 1989 Jul; 257(1 Pt 2):F99-106. PubMed ID: 2750929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamm-Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function.
    Jaggi M; Nakagawa Y; Zipperle L; Hess B
    Urol Res; 2007 Apr; 35(2):55-62. PubMed ID: 17345077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Tamm-Horsfall protein in a rat nephrolithiasis model.
    Gokhale JA; Glenton PA; Khan SR
    J Urol; 2001 Oct; 166(4):1492-7. PubMed ID: 11547119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Uronic-acid-rich protein: a new glycoprotein inhibiting the crystallization of calcium oxalate in vitro].
    Atmani F; Lacour B; Daudon M
    Nephrologie; 1996; 17(3):157-62. PubMed ID: 9064564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoprotein calcium oxalate crystal growth inhibitor in urine.
    Worcester EM; Nakagawa Y; Coe FL
    Miner Electrolyte Metab; 1987; 13(4):267-72. PubMed ID: 3306319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of stone formation.
    Worcester EM
    Semin Nephrol; 1996 Sep; 16(5):474-86. PubMed ID: 8890402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased renal expression of the putative calcium oxalate inhibitor Tamm-Horsfall protein in the ethylene glycol rat model of calcium oxalate urolithiasis.
    Marengo SR; Chen DH; Kaung HL; Resnick MI; Yang L
    J Urol; 2002 May; 167(5):2192-7. PubMed ID: 11956477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors within the nephron.
    Coe FL; Nakagawa Y; Parks JH
    Am J Kidney Dis; 1991 Apr; 17(4):407-13. PubMed ID: 2008908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole urinary proteins coat calcium oxalate monohydrate crystals to greatly decrease their adhesion to renal cells.
    Kumar V; Farell G; Lieske JC
    J Urol; 2003 Jul; 170(1):221-5. PubMed ID: 12796693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamm-Horsfall glycoprotein--inhibitor or promoter of calcium oxalate monohydrate crystallization processes?
    Hess B
    Urol Res; 1992; 20(1):83-6. PubMed ID: 1736492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of gender and age on calcium oxalate crystal growth inhibition by urine from relatives of stone forming patients.
    Bergsland KJ; Kinder JM; Asplin JR; Coe BJ; Coe FL
    J Urol; 2002 Jun; 167(6):2372-6. PubMed ID: 11992040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting the regrowth of renal stones in vitro: a contribution to the understanding of renal stone development.
    Costa-Bauzá A; Isern B; Perelló J; Sanchis P; Grases F
    Scand J Urol Nephrol; 2005; 39(3):194-9. PubMed ID: 16118089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.